Literature DB >> 8310301

Chemotherapy of metastatic endometrial cancer.

H B Muss1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8310301

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure.

Authors:  Yasukazu Sagawa; Atsuya Fujitoh; Hirotaka Nishi; Hiroe Ito; Tamaki Yudate; Keiichi Isaka
Journal:  Tumour Biol       Date:  2010-11-27

Review 3.  Systemic therapy for advanced or recurrent endometrial carcinoma.

Authors:  G F Fleming
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

4.  Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma.

Authors:  Kazuko Fujiwara; Tomomi Egawa-Takata; Yutaka Ueda; Toshihiro Kimura; Kiyoshi Yoshino; Masami Fujita; Takashi Miyatake; Yukinobu Ohta; Shoji Kamiura; Takayuki Enomoto; Tadashi Kimura
Journal:  Arch Gynecol Obstet       Date:  2011-11-30       Impact factor: 2.344

Review 5.  Adjuvant therapy for endometrial cancer.

Authors:  Maria C Deleon; Natraj R Ammakkanavar; Daniela Matei
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

6.  Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.

Authors:  Shin Wha Lee; Taek Sang Lee; Dae Gy Hong; Jae Hong No; Dong Choon Park; Jae Man Bae; Seok Ju Seong; So Jin Shin; Woong Ju; Keun Ho Lee; Yoo Kyung Lee; Hanbyoul Cho; Chulmin Lee; Jiheum Paek; Hyun Jung Kim; Jeong Won Lee; Jae Weon Kim; Duk Soo Bae
Journal:  J Gynecol Oncol       Date:  2016-10-27       Impact factor: 4.401

7.  Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines.

Authors:  François Fabi; Pascal Adam; Sophie Parent; Laurence Tardif; Monique Cadrin; Eric Asselin
Journal:  Mol Oncol       Date:  2021-01-04       Impact factor: 6.603

8.  Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy.

Authors:  I Otsuka; T Kubota; T Aso
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.